Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. - Lindholm,L.H.; Ibsen,H.; Dahlof,B. (Lancet, 2002)